Details of Disease
General Information of Disease (ID: DIS5UKG5)
| Disease Name | Bladder squamous cell carcinoma | |||||
|---|---|---|---|---|---|---|
| Synonyms |
BLSC; urinary bladder squamous cell carcinoma; urinary bladder epidermoid carcinoma; squamous cell carcinoma of urinary bladder; squamous cell carcinoma of the urinary bladder; squamous cell carcinoma of the bladder; squamous cell carcinoma of bladder; epidermoid carcinoma of urinary bladder; epidermoid carcinoma of the urinary bladder; epidermoid carcinoma of the bladder; epidermoid carcinoma of bladder; bladder squamous cell carcinoma; bladder squamous cell cancer; bladder epidermoid carcinoma
|
|||||
| Definition |
A squamous cell carcinoma of the bladder arising from metaplastic epithelium. It represents less than 10% of bladder carcinomas. The exception is the Middle East along the Nile Valley, where it represents the most common form of carcinoma because of the endemic nature of schistosomiasis. Bladder squamous cell carcinoma is often associated with long-standing chronic inflammation of the bladder and usually has a poor prognosis. The diagnosis of squamous cell carcinoma of the bladder should be reserved for those tumors that are predominantly keratin forming.
|
|||||
| Disease Hierarchy | ||||||
| Disease Identifiers | ||||||
Drug-Interaction Atlas (DIA) of This Disease
| Drug-Interaction Atlas (DIA) | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
This Disease is Treated as An Indication in 1 Approved Drug(s)
|
|||||||||||||||||||||||||